EGR3

STAINING OVERVIEW

? »

Overall cancer tissue 
staining statistics


0%
25%
50%
75%
100%

Tissue presentation order

Histological

Alphabetical

 

Antibody HPA006206

Antibody CAB009373

Tissue

Antibody staining

Antibody staining

Colorectal cancer
Breast cancer
Prostate cancer
Ovarian cancer
Cervical cancer
Endometrial cancer
Carcinoid
Head and neck cancer
Thyroid cancer
Glioma
Lymphoma
Lung cancer
Melanoma
Skin cancer
Testis cancer
Urothelial cancer
Renal cancer
Stomach cancer
Pancreatic cancer
Liver cancer

Summary

A majority of malignant cells showed moderate cytoplasmic staining with a granular pattern, often accompanied with nuclear staining in a fraction of the cells. Several prostate cancers were strongly stained, while most testicular, urothelial, renal and hepatocellular carcinomas were weakly stained or negative.Mucinous ovarian cancers and fractions of cells in cases of colorectal cancers displayed strong staining. A majority of testicular cancers as well as a few breast, prostate, skin and urothelial cancers displayed moderate cytoplasmic positivity. Subsets of cells in malignant gliomas showed moderate nuclear staining. Malignant cells in general showed weak staining or were negative.

Validation

Uncertain: Two (or more) antibodies yielding dissimilar or partly similar staining patterns and there is no available gene/protein characterization data or only limited gene/protein characterization data
Uncertain: Two (or more) antibodies yielding dissimilar or partly similar staining patterns and there is no available gene/protein characterization data or only limited gene/protein characterization data

Level of antibody staining/expression





High
Medium
Low
Not detected